Uremic toxin-activated AhR exerts detrimental biological effects on the development of CKD, CKD-associated cognitive impairment, anxiety, obstructive sleep apnea, ischemic myopathy and CVD, and DN. Here, AHR is linked to obstructive sleep apnea syndrome.